WeInfuse

Web-based management for infusion centers

Austin, Texas, United States

About WeInfuse

WeInfuse provides a web-based application specifically designed for infusion centers that administer specialty biologic medications. This application centralizes and streamlines various management tasks, including scheduling, inventory management, billing, and compliance tracking, which are essential for the efficient operation of these healthcare facilities. Unlike many competitors, WeInfuse focuses exclusively on the unique needs of infusion centers, addressing significant challenges in an under-resourced area of the healthcare sector. The company's goal is to enhance operational efficiency and improve patient care by offering a comprehensive solution that helps clients optimize their operations and reduce costs. WeInfuse operates on a subscription-based model, ensuring a steady income stream while supporting the rapidly growing market for specialty biologic medications.

Austin, TexasHeadquarters
2016Year Founded
GROWTH_EQUITY_VCCompany Stage
Enterprise Software, HealthcareIndustries
11-50Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Vacation
Paid Parental Leave
401(k) Retirement Plan
Phone/Internet Stipend

Risks

Integration challenges with Tennr's AI could lead to data inaccuracies affecting patient care.
Reliance on third-party platforms like Twilio may expose WeInfuse to security vulnerabilities.
Expansion into neurology practices may strain resources due to platform adaptation needs.

Differentiation

WeInfuse offers a comprehensive platform for infusion center management, enhancing operational efficiency.
The platform integrates with AI solutions like Tennr for automated data extraction and processing.
WeInfuse's partnerships with Formstack and Twilio enhance patient engagement and communication.

Upsides

The partnership with Annexus Health improves patient access to financial assistance for treatments.
Integration with SamaCare streamlines prior authorizations, reducing administrative burdens for infusion centers.
Growth investment from Curewell Capital supports platform expansion and strategic initiatives.